Pharmaceutical Industry

Page 3 of 100

Emma Walmsley, chief executive officer of GSK Plc, following a Bloomberg Television interview in London, UK, on Tuesday, July 16, 2024. The threat of superbugs is not sufficiently understood, Walmsley said.
Leadership

GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt

By
April 2, 2025
Photo of Mark Cuban
Health

Mark Cuban warns Trump’s tariffs mean his Cost Plus Drugs ‘won’t have a choice’ but to raise prices for consumers

By
April 1, 2025
Katherine Stueland
Tech

As a kid, she raised money to cure cystic fibrosis. Now she’s the CEO of a $2.6 billion genetic testing company

By
March 31, 2025
Vietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory
Finance

Vietnam seizes 1.4 tons of ketamine as police bust country’s biggest synthetic drug factory

By
March 27, 2025
Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate
Tech

Sanofi’s chief digital officer says remote work means employees lose the ‘serendipity’ needed to innovate

By
March 27, 2025
‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
Tech

‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse

By
March 25, 2025
AstraZeneca to buy cell therapy biotech for up to $1 billion
Tech

AstraZeneca to buy cell therapy biotech for up to $1 billion

By Ashleigh Furlong and Bloomberg
March 17, 2025
My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup
Commentary

My son’s rare disease diagnosis spurred me to ditch Big Pharma for a biotech startup

By
March 10, 2025
Interest in GLP-1 medications like Ozempic will continue to grow given the multiple health conditions they can improve.
Commentary

The crisis over GLP-1 out-of-pocket costs deepens—it’s time for health-care leaders to step up

By
March 4, 2025
Anne Wojcicki on stage at a conference
Leadership

A few years ago 23andMe was worth $6 billion. Now CEO Anne Wojcicki is trying to buy it back for $42 million

By
March 1, 2025
Emma Walmsley, chief executive officer of GlaxoSmithKline speaks during the Clinton Global Initiative annual meeting in New York City on September 24, 2024.
Health

GSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.

By
February 28, 2025
Eli Lilly's headquarters sits behind a gate with the US flag raised
Finance

Eli Lilly to spend $27 billion to bolster U.S. drug manufacturing as Trump tariffs loom

By Madison Muller and Bloomberg
February 26, 2025
Bayer CEO Bill Anderson on diversity initiatives, new menopause drugs and how to tame a runaway bureaucracy
Leadership

Bayer CEO Bill Anderson on diversity initiatives, new menopause drugs and how to tame a runaway bureaucracy

By
February 26, 2025
Robert F. Kennedy Jr.
Health

With RFK Jr. in charge, supplement makers see chance to cash in

By KFF Health News and Arthur Allen
February 25, 2025
Semaglutide medications Wegovy and Ozempic are pictured
Health

Wegovy, Ozempic shortage declared over, hitting copycats like Hims & Hers

By Bloomberg, Madison Muller, Ike Swetlitz and Naomi Kresge
February 21, 2025

Most Popular